Pre-Market 25 Feb 2026: L.TO Loblaw (TSX) earnings spotlight: key numbers ahead
L.TO stock opens pre-market at C$67.52 as Loblaw Companies Limited prepares to report earnings on 25 Feb 2026. Price is down -2.51% from the prior close, with volume running at 2,172,247 shares. Investors will watch same-store sales, pharmacy margins, and PC Optimum engagement. Management guidance and capital spend plans — including a C$2.4 billion 2026 investment — are likely to move the stock in the TSX pre-market session.
Immediate price action and estimates for L.TO stock
L.TO stock trades at C$67.52 after an intraday high of C$69.59 and low of C$66.69. The one-day move is -2.51% and relative volume is 1.57, signalling heavier trading than average. Analysts and algorithms will compare reported EPS to the company EPS of 2.05 and the market PE of 32.94 to judge surprises.
Pre-market activity reflects investor focus on both retail margins and Loblaw’s announced investment program. Expect volatility around the earnings call at 13:30 EST and possible gap moves into the TSX open.
Earnings catalysts and guidance that will move L.TO stock
Key catalysts are same-store sales growth, pharmacy and clinic performance, and PC Optimum membership trends. Loblaw’s recent announcement to invest C$2.4 billion in 2026 adds a growth narrative, with 70 new stores and 9,700 jobs cited by management source.
Investors will also watch margin commentary and capital allocation priorities. Any bullish guidance or stronger-than-expected gross margin could quickly push L.TO stock higher in the session.
Loblaw financials and valuation snapshot for L.TO stock
Loblaw reports EPS 2.05, market cap C$79.75B, and reported PE 32.94 this session. Trailing metrics show strong cash flow per share at 18.48 and free cash flow per share 12.27. Dividend per share is 0.94, for a yield near 1.39%.
Balance sheet ratios matter: debt-to-equity is 1.75 and interest coverage is 4.84, indicating leverage that investors should weigh against steady retail cash flow. Price averages of C$63.29 (50-day) and C$58.36 (200-day) provide technical support context.
Meyka AI rates L.TO with a score out of 100 and forecast
Meyka AI rates L.TO with a score out of 100: 75.51 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are model outputs and are not guaranteed; we are not financial advisors.
Meyka AI’s forecast model projects a 12-month price of C$134.81, a monthly target of C$67.44, and a quarterly estimate of C$43.62. The 12-month projection implies an upside of 99.70% versus the current C$67.52. Forecasts are model-based projections and not guarantees. For company filings and market news, see Reuters coverage source.
Technical and trading setup for L.TO stock
Technicals show an RSI of 58.02 and ADX 29.16, indicating a moderately strong trend. Bollinger Bands sit at Upper 71.18 / Middle 65.99 / Lower 60.81, suggesting a trading range with upside resistance near the year high C$69.59.
Short-term support aligns with the 50-day average C$63.29. Traders may use a pre-market range break strategy, but be mindful of post-earnings spreads and liquidity shifts. Average volume is 1,368,954 shares; today’s volume is above average.
Risks, sector context, and investor takeaways for L.TO stock
Risks include margin pressure from discount channels, integration costs from store expansion, and leverage sensitivity to higher interest rates. Loblaw sits in the Consumer Defensive sector, where peers show average PE around 30.59 and steadier yields. Sector performance has outpaced some cyclicals, making valuation comparisons important.
Investors should weigh steady cash flow and a B+ Meyka grade against debt metrics and a PE that reflects expected earnings growth. Use position sizing and watch company guidance for conviction after the call.
Final Thoughts
L.TO stock enters the pre-market session at C$67.52 with active volume and a clear earnings spotlight for 25 Feb 2026. Short-term moves will hinge on Loblaw Companies Limited’s same-store sales, pharmacy margins, and details on the planned C$2.4 billion 2026 investment program. Our metrics show solid cash generation, an EPS of 2.05, and a dividend yield near 1.39%, but leverage requires attention. Meyka AI rates the stock 75.51/100 (B+, BUY) and its model projects C$134.81 in 12 months, implying 99.70% upside versus today’s price. That projection is model-based and not guaranteed. For traders, watch intraday range breaks and guidance tone. For investors, focus on how management translates capital spend into comp growth and margins. We will monitor the TSX open and update our Meyka AI-powered market analysis page for L.TO after the release
FAQs
When will Loblaw report earnings and how will that affect L.TO stock?
Loblaw reports on 25 Feb 2026 at 13:30 EST. Expect L.TO stock volatility as investors digest same-store sales, pharmacy margins, and capital spending guidance. Positive surprises typically lift the TSX stock, while weak margin commentary can trigger pullbacks.
What is Meyka AI’s short-term price view for L.TO stock?
Meyka AI’s short-term monthly forecast is C$67.44 and the quarterly projection is C$43.62. These are model outputs based on current data and not guarantees. Traders should combine this with real-time earnings results and guidance.
How does Loblaw’s valuation compare within its sector for L.TO stock?
Loblaw’s market PE is 32.94 and the consumer defensive sector average PE is near 30.59. Loblaw trades with a premium tied to scale and cash flow, but investors should weigh this against its 1.75 debt-to-equity ratio and interest coverage.
What are the main risks investors should watch for in L.TO stock?
Key risks include margin compression from discount banners, execution costs for the C$2.4 billion expansion, and sensitivity to higher interest costs. Monitoring guidance and cash flow statements after the report will be critical for L.TO stock holders.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.